Tananbaum James B.
CIK 0001581754
President and CEODirector10% Owner
Filings
18
Latest Apr 3, 2026
Issuers covered
4
Showing
18 of 18
Page 1
Track record
11 of 19 open-market trades scored (58% price coverage) - 8 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 64% | +37.2% | +43.7% | +89.8% | -28.3% |
| 90 days | 11 | 64% | +152.5% | +24.9% | +376.8% | -14.8% |
| 180 days | 9 | 78% | +126.7% | +201.9% | +279.4% | -40.0% |
| 365 days | 4 | 50% | +196.1% | +187.1% | +486.2% | -75.9% |
Issuers
Companies where Tananbaum James B. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALMS | Alumis Inc. | 6 | Apr 3, 2026 |
| PRDS | Pardes Biosciences, Inc. | 6 | Aug 31, 2023 |
| KNTE | Kinnate Biopharma Inc. | 4 | Apr 5, 2024 |
| THRX | Theseus Pharmaceuticals, Inc. | 2 | Jul 19, 2023 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|